SEASON South East Asian Study Of Novel Genotypes in Hepatitis C Infection: Pegylated-interferon and ribavirin therapy (PEGATRON REDIPEN combination therapy (PEG-Intron(R) REDIPEN Plus REBETOL(R))) in treatment naive patients With genotypes 1, 6, 7, 8, 9: A comparison of race and genotype on treatment outcome.
Phase of Trial: Phase IV
Latest Information Update: 04 Mar 2015
At a glance
- Drugs Peginterferon alfa-2b/ribavirin (Primary) ; Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Pharmacogenomic; Therapeutic Use
- Acronyms SEASON
- Sponsors Schering-Plough
- 12 Jan 2010 Actual end date (Dec 2007) and actual noumber of patients (121) added as reported by ClinicalTrials.gov.
- 12 Jan 2010 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 26 Mar 2008 The expected completion date for this trial is now 1 Dec 2007, as reported by clinicaltrials.gov.